Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy

BACKGROUND/AIMS: To evaluate the impact of isoniazid (INH) treatment for latent tuberculosis infection (LTBI) on the development of liver function test (LFT) abnormality and the persistence of tumor necrosis factor (TNF) inhibitors in rheumatoid arthritis (RA) patients. METHODS: We retrospectively e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Intern Med
Egile Nagusiak: Sung, Yoon-Kyoung, Cho, Soo-Kyung, Kim, Dam, Won, Soyoung, Choi, Chan-Bum, Kim, Tae-Hwan, Jun, Jae-Bum, Yoo, Dae-Hyun, Bae, Sang-Cheol
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association of Internal Medicine 2018
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6129622/
https://ncbi.nlm.nih.gov/pubmed/28288508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.214
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak